Neuroblastoma Drugs Market Analysis

Mechanism Type (Antibiotics, Microtubule Inhibitors, Alkylating Agents)

The market is segmented and analyzed for demand and supply by mechanism type into antibiotics, microtubule inhibitors, alkylating agents, and others. Out of these types, the antibiotics segment is estimated to gain the largest market share of about 42% in the year 2037. The growth of the segment can be attributed to the increasing use of antibiotics for neuroblastoma. The rising applications of antibiotics such as tigecycline which is an expanded spectrum antibiotic in cancer therapy are also estimated to drive the market segment growth during the forecast period. The growing population who uses antibiotics against neuroblastoma to produce anti-proliferative effects on the cells is also estimated to hike the market segment growth. The use of antibiotics suppresses the growth of tumor cell colonies thereby reducing the further spread of cancer to other parts which is anticipated to have a positive impact on the market segment growth. Every year more than 250 million antibiotic prescriptions are given in the U.S. as of 2019.

Treatment Type (Chemotherapy, Bone Marrow Transplantation, Retinoid Therapy, Immunotherapy, Surgery)

The neuroblastoma drugs market is also segmented and analyzed for demand and supply by treatment type into chemotherapy, bone marrow transplantation, retinoid therapy, immunotherapy, and surgery. Amongst these three segments, the chemotherapy segment is expected to garner a significant share of around 32% in the year 2037. The chemotherapy segment is anticipated to witness significant growth on the back of the rising usage of chemotherapy drugs such as doxorubicin and carboplatin in order to destroy cancer cells. Moreover, chemotherapy is used as a primary treatment for cancer as it helps in the shrinkage of tumor cells which makes other treatments such as surgery or radiation possible. Besides drug therapy, chemotherapy is the next best treatment method to improve cancer conditions and is thus estimated to hike the segment growth. The number of chemotherapy centers in clinics and hospitals owing to the improvement in the infrastructure of public and private sectors is anticipated to rise the demand for market segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments: